The Iron-Sulfur Cluster Crisis: Why Your Mitochondria Can't Recover (And Why Practitioners Don't Talk About It)

What Are Iron-Sulfur Clusters, and Why Should You Care?

Iron-sulfur clusters (Fe-S clusters) are not some exotic compound. They’re the workhorses of mitochondrial function—literally atoms of iron and sulfur bonded together to form functional clusters that sit at the heart of nearly every energy-producing enzyme in your cells.

Think of them as the rivets holding together the electron transport chain.

Your Complex I, II, and III—the machinery that pumps protons and generates the voltage that powers ATP synthesis—depend on Fe-S clusters to function. So does aconitase (in the Krebs cycle), which converts citrate into isocitrate. So does multiple enzymes involved in amino acid metabolism, DNA repair, and detoxification.

Without intact Fe-S clusters, your mitochondrial engine doesn’t just run slowly. It stalls.

The Dysbiosis-Iron-Sulfur Connection: A Two-Way Street

Here’s what conventional gastroenterology misses: dysbiosis doesn’t just produce problematic metabolites. It dismantles the host’s ability to assemble and maintain Fe-S clusters. This happens through two overlapping mechanisms.

Mechanism 1: Iron Dysmetabolism

Dysbiotic bacteria have evolved to compete for iron. Pathogenic organisms like Clostridioides difficile, pathogenic E. coli, and various Proteobacteria produce siderophores—iron-chelating compounds that scavenge iron from the mucosa and colonocyte cytoplasm. They literally steal iron that should be bound for Fe-S cluster assembly.

Simultaneously, dysbiosis disrupts the microbiome’s ability to regulate iron absorption. Commensal bacteria maintain local pH and produce compounds that keep iron in an absorbable form. When dysbiosis takes hold, the gradient collapses. Iron bioavailability crashes. The colonocyte starves.

But here’s the deeper problem: even if iron is available, the dysbiotic environment—particularly high sulfide production from sulfate-reducing bacteria and the altered fermentation profile—shifts intestinal pH and redox state. Iron becomes trapped in forms the colonocyte can’t transport. Bioavailability falls further.

Mechanism 2: Sulfur Dysmetabolism and Cysteine Depletion

Fe-S clusters require sulfur. The primary source is the amino acid cysteine, which your body converts into sulfide for cluster assembly.

Dysbiosis disrupts this pipeline at multiple points:

Taurine and cysteine metabolism collapse. Healthy dysbiosis maintains a consortium that produces taurine-degrading enzymes and regulates cysteine fermentation. Dysbiotic organisms overgrow bacteria that either hoard cysteine or convert it into toxic sulfides faster than the host can use them. Cysteine availability plummets while local sulfide accumulates—toxic to colonocyte mitochondria.

Hydrogen sulfide toxicity rises. Sulfate-reducing bacteria thrive in dysbiotic conditions, pumping out hydrogen sulfide. In healthy conditions, sulfide is metabolized to thiosulfate and sulfate by the enzyme sulfide quinone oxidoreductase (SQR). But when dysbiosis persists, sulfide production overwhelms the host’s capacity to detoxify it.

This sulfide then acts as mitochondrial poison—binding to cytochrome c oxidase (Complex IV) and directly inhibiting electron transport. And here’s the vicious spiral: impaired mitochondrial function means the colonocyte produces less ATP. Tighter colonocyte metabolism means sulfide clearance slows further. Dysbiosis worsens.

The Colonocyte Trap: Fe-S Cluster Assembly Failure

Now combine these two failures: iron starvation + sulfur dysmetabolism.

The colonocyte’s mitochondria can no longer assemble new Fe-S clusters. The enzymes responsible for cluster synthesis—including the ISCU complex—require both iron and sulfur-containing substrates. When either is missing, the system grinds to a halt.

What happens next?

Existing Fe-S clusters in Complex I, II, and III begin to degrade. They’re not permanent—they’re constantly turned over and recycled. Without replenishment, they rust out.

Your colonocyte’s electron transport chain loses fidelity. Proton pumping becomes less efficient. Mitochondrial membrane potential declines. ATP production crashes. The colonocyte loses its primary energy source and its ability to maintain the tight junction barrier that keeps dysbiotic endotoxin at bay.

This is the real pathophysiology of SIBO and chronic IBS that most practitioners never discuss.

Why This Matters in SIBO and Chronic Dysbiosis

SIBO isn’t primarily a bacterial overgrowth problem—it’s a host compartmentalization failure.

The small intestine should be hostile to fermentation. Rapid transit, alkaline pH, low substrate availability, and robust intestinal motility should prevent bacterial dominance. But SIBO persists because the host has failed. And a major part of that failure is mitochondrial.

When colonocyte (and small intestinal epithelial cell) mitochondria lose Fe-S cluster integrity:

• ATP production collapses, so tight junctions weaken

• Motility drivers—the migrating motor complex—require ATP-dependent coordination. Dysfunction spreads upward

• The local immune response becomes incoherent; dysbiosis-driving microbes aren’t cleared effectively

• Butyrate, normally a fuel, becomes a toxin that accumulates due to impaired oxidative metabolism

• The redox gradient that selects against facultative anaerobes collapses, further favoring dysbiosis

The microbes aren’t the primary driver. They’re the consequence of host failure. And the failure isn’t just about butyrate sensitivity or epithelial permeability—it’s about the inability to manufacture and maintain the substratum of all aerobic life: functional Fe-S clusters.

Why Practitioners Focus Everywhere Else

Why is this so invisible in functional medicine?

Because Fe-S clusters are infrastructure. They’re not flashy. They don’t show up on microbiome tests. They’re not addressed by any standard supplement protocol. And they require understanding metabolic biochemistry, not just dysbiosis metaphors.

Most practitioner frameworks are built around two ideas: (1) kill the bad bacteria, (2) feed the good bacteria. Neither addresses the host’s mitochondrial substrate crisis.

Dysbiosis disrupts iron. Dysbiosis disrupts sulfur homeostasis. This prevents Fe-S cluster assembly. Mitochondrial dysfunction deepens. Dysbiosis perpetuates. You get stuck.

What This Means for Understanding Your Condition

If you’ve been treated for SIBO or IBS with antimicrobials, probiotics, and dietary strategies—and you’ve still relapsed—there’s a reason. The interventions targeted the microbiome. But the microbiome isn’t the bottleneck. The host’s capacity to maintain Fe-S cluster homeostasis is.

This isn’t speculation. It’s baked into mitochondrial biochemistry. It’s the reason isolated microbiome interventions often fail. And it’s why understanding your mitochondrial substrate capacity—not just your bacterial composition—is essential.

The iron you absorb, the sulfur your dysbiotic microbiota allows you to retain, the efficiency of your colonocyte’s Fe-S cluster assembly machinery—these are the real levers.

Most practitioners never measure them. They never discuss them. So the cycle continues.

What Now?

If you’re interested in investigating whether Fe-S cluster dysfunction is part of your story—whether iron and sulfur homeostasis are driving your relapsing dysbiosis and mitochondrial symptoms—that requires a different kind of analysis.

It requires looking at iron metabolism markers (ferritin, serum iron, TIBC), sulfur-dependent pathways (organic acids for sulfation capacity), microbial metabolites (H2S producing potential from shotgun metagenomics), and markers of mitochondrial health (NAD+ availability, Complex activity, ATP production).

It also requires understanding how dysbiosis specifically disrupts your iron and sulfur ecology—not just generalized microbiome concepts.

This is where consultation comes in. Understanding whether Fe-S cluster disruption is a primary driver of your condition—and if so, what that means for your path forward—requires analysis you won’t find in standard practice.

If you want to explore whether this missing piece is part of your picture, I’m available for case consultation. We’d look at your specific biochemical markers, your dysbiosis pattern, and your colonocyte’s capacity to maintain Fe-S cluster homeostasis.

Because until that infrastructure is addressed, relapse is predictable. And that’s a pattern worth breaking.

Mohammed Attallah is an independent systems biology researcher developing the Host Capacity Model of chronic gut dysfunction. He works with clients to identify mitochondrial substrate bottlenecks underlying dysbiosis and chronic GI disease. Available for consultation at research@biomelogic.net.